| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.4 | 1e-28 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.31 | 6e-18 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-16 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-15 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-13 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-11 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.3 | 1e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |